[{"_id":"551f89b731cae9239deb1f3b","会社名":"大幸薬品(株)【4574】","証券コード":"4574","決算期":"2014年3月期","会計方式":"日本方式","決算発表日":"2014年5月13日","決算月数":"12か月","売上高":"9,947百万円","営業利益":"2,590百万円","経常利益":"2,683百万円","当期利益":"1,747百万円","EPS（一株当たり利益）":"135.94円","調整一株当たり利益":"131.56円","BPS（一株当たり純資産）":"872.65円","総資産":"16,622百万円","自己資本":"11,343百万円","資本金":"286百万円","有利子負債":"---","自己資本比率":"68.2%","ROA（総資産利益率）":"11.79%","ROE（自己資本利益率）":"16.83%","総資産経常利益率":"18.11%","__v":0,"日付":"2015-04-04T06:50:31.722Z"},{"_id":"551f89b731cae9239deb1f3c","会社名":"大幸薬品(株)【4574】","証券コード":"4574","決算期":"2013年3月期","会計方式":"日本方式","決算発表日":"2013年5月13日","決算月数":"12か月","売上高":"7,443百万円","営業利益":"1,120百万円","経常利益":"1,211百万円","当期利益":"1,037百万円","EPS（一株当たり利益）":"81.31円","調整一株当たり利益":"80.09円","BPS（一株当たり純資産）":"742.84円","総資産":"13,016百万円","自己資本":"9,420百万円","資本金":"178百万円","有利子負債":"---","自己資本比率":"72.4%","ROA（総資産利益率）":"8.21%","ROE（自己資本利益率）":"11.42%","総資産経常利益率":"9.58%","__v":0,"日付":"2015-04-04T06:50:31.723Z"},{"_id":"551f89b731cae9239deb1f3d","会社名":"大幸薬品(株)【4574】","証券コード":"4574","決算期":"2012年3月期","会計方式":"日本方式","決算発表日":"2012年5月14日","決算月数":"12か月","売上高":"6,683百万円","営業利益":"515百万円","経常利益":"558百万円","当期利益":"482百万円","EPS（一株当たり利益）":"37.23円","調整一株当たり利益":"36.51円","BPS（一株当たり純資産）":"673.11円","総資産":"12,261百万円","自己資本":"8,740百万円","資本金":"155百万円","有利子負債":"---","自己資本比率":"71.3%","ROA（総資産利益率）":"4.10%","ROE（自己資本利益率）":"5.66%","総資産経常利益率":"4.75%","__v":0,"日付":"2015-04-04T06:50:31.723Z"}]